Rifabutin: Difference between revisions
Jump to navigation
Jump to search
| Line 19: | Line 19: | ||
'''| [[Rifabutin adverse reactions|Adverse Reactions]]''' | '''| [[Rifabutin adverse reactions|Adverse Reactions]]''' | ||
'''| [[Rifabutin overdosage|Overdosage]]''' | '''| [[Rifabutin overdosage|Overdosage]]''' | ||
'''| [[Rifabutin dosage and administration|Dosage and Administration]]''' | '''| [[Rifabutin dosage and administration|Dosage and Administration]]''' | ||
'''| [[Rifabutin how supplied|How Supplied]]''' | '''| [[Rifabutin how supplied|How Supplied]]''' | ||
Revision as of 02:14, 31 December 2013
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
Overview
Category
US Brand Names
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Overdosage | Dosage and Administration | How Supplied | Labels and Packages